AU4995397A - Composition, for the treatment of asthma, containing loratadine and a decongestant - Google Patents

Composition, for the treatment of asthma, containing loratadine and a decongestant

Info

Publication number
AU4995397A
AU4995397A AU49953/97A AU4995397A AU4995397A AU 4995397 A AU4995397 A AU 4995397A AU 49953/97 A AU49953/97 A AU 49953/97A AU 4995397 A AU4995397 A AU 4995397A AU 4995397 A AU4995397 A AU 4995397A
Authority
AU
Australia
Prior art keywords
decongestant
asthma
treatment
composition
containing loratadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU49953/97A
Other versions
AU731756B2 (en
Inventor
Alan G. Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU4995397A publication Critical patent/AU4995397A/en
Application granted granted Critical
Publication of AU731756B2 publication Critical patent/AU731756B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU49953/97A 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant Ceased AU731756B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
US08/739669 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (2)

Publication Number Publication Date
AU4995397A true AU4995397A (en) 1998-05-22
AU731756B2 AU731756B2 (en) 2001-04-05

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49953/97A Ceased AU731756B2 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
AR022378A1 (en) * 1998-09-10 2002-09-04 Schering Corp METHODS AND COMPOSITIONS TO TREAT SINUSITIS, MEDIUM OTITIS AND OTHER RELATED DISORDERS USING ANTIHISTAMINS
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
ATE253354T1 (en) * 1999-02-23 2003-11-15 Yuhan Corp CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
JP5592042B2 (en) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド Single dose antihistamine / decongestant formulation for the treatment of rhinitis
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
MXPA03011705A (en) * 2001-06-20 2004-03-19 Schering Corp Antihistamines for the treatment of nasal congestion and nasal obstruction.
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2366381A1 (en) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
HUP9904075A3 (en) 2002-02-28
EP0941091A1 (en) 1999-09-15
CO4910128A1 (en) 2000-04-24
CZ150999A3 (en) 1999-10-13
KR20000052922A (en) 2000-08-25
BR9712705A (en) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (en) 2000-05-28
JP2000505104A (en) 2000-04-25
PE11399A1 (en) 1999-02-09
CA2268546A1 (en) 1998-05-07
AR008908A1 (en) 2000-02-23
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (en) 2000-04-20
TR199901003T2 (en) 1999-07-21
NO992062L (en) 1999-04-29
SK54599A3 (en) 2000-08-14
CN1235545A (en) 1999-11-17
PL333056A1 (en) 1999-11-08
IL129662A0 (en) 2000-02-29
NO992062D0 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
AU1618697A (en) Novel compounds and pharmaceutical use thereof
NZ294392A (en) Asthma drugs and compounds
AU2839997A (en) Medical devices
AU3003295A (en) Improved inhaler and medicated package
AU3201097A (en) Catheter package
AU3532195A (en) Medicaments
AU4995397A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
EP0691670A3 (en) A combination of materials for mercury-dispensing devices, method of preparation and devices thus obtained
AU5289698A (en) Gas treatment devices
AU3506897A (en) Nitrogen oxide adsorbing material
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
AU3027297A (en) New thiazolidinediones, process for preparing the same and medicaments containing the same
AU4636396A (en) Antiglucocorticoid medicament
AU4382197A (en) Inhaler device
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU3273497A (en) Inhaling device
AU7675198A (en) Sucralfate-containing composition and process for the preparation thereof
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU2172097A (en) Infusion packages and methods for their manufacture
AU1752795A (en) Inhalator
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU3360697A (en) Rotary reactor and use thereof
AU3924997A (en) A process for the preparation of granulated materialistribution, and a device for carrying out said process

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired